Ind-Swift Laboratories Limited Cash Flow Conversion Efficiency

Latest as of September 2025: -0.015x

Ind-Swift Laboratories Limited cash flow conversion efficiency. Based on the latest financial reports, Ind-Swift Laboratories Limited (INDSWFTLAB) has a cash flow conversion efficiency ratio of -0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-202.50 Million ≈ $-2.19 Million USD) by net assets (Rs13.07 Billion ≈ $141.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Ind-Swift Laboratories Limited (2006–2025)

Cash flow conversion efficiency of Ind-Swift Laboratories Limited from 2006 to 2025. This chart illustrates how Ind-Swift Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View INDSWFTLAB share price today for real-time trading data and today's change.

Ind-Swift Laboratories Limited Cash Flow Conversion Ratio Explained

Ind-Swift Laboratories Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Ind-Swift Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ind-Swift Laboratories Limited ranked by their cash flow conversion efficiency. Also see Ind-Swift Laboratories Limited market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Jiangsu Chunlan Refrigerating Equipment Stock Co Ltd
SHG:600854
0.006x
Refex Industries Limited
NSE:REFEX
0.049x
Xiamen Goldenhome Co Ltd
SHG:603180
-0.078x
Five Point Holdings LLC
NYSE:FPH
-0.004x
Norske Skog Asa
OL:NSKOG
-0.052x
Digiworld Corp
VN:DGW
0.215x
Hangzhou Coco Healthcare Products Co.Ltd.
SHE:301009
-0.012x
Beijing Sanfo Outdoor Products Co Ltd
SHE:002780
-0.026x

Annual Cash Flow Conversion Efficiency for Ind-Swift Laboratories Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Ind-Swift Laboratories Limited from 2006 to 2025. Review Ind-Swift Laboratories Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs11.73 Billion
≈ $126.85 Million
Rs-254.74 Million
≈ $-2.75 Million
-0.022x +89.19%
2024-03-31 Rs8.12 Billion
≈ $87.82 Million
Rs-1.63 Billion
≈ $-17.64 Million
-0.201x -170.38%
2023-03-31 Rs6.82 Billion
≈ $73.75 Million
Rs1.95 Billion
≈ $21.05 Million
0.285x +14.11%
2022-03-31 Rs6.01 Billion
≈ $64.98 Million
Rs1.50 Billion
≈ $16.25 Million
0.250x +11.83%
2021-03-31 Rs6.03 Billion
≈ $65.26 Million
Rs1.35 Billion
≈ $14.59 Million
0.224x +14.40%
2020-03-31 Rs6.41 Billion
≈ $69.28 Million
Rs1.25 Billion
≈ $13.54 Million
0.195x +278.44%
2019-03-31 Rs5.88 Billion
≈ $63.57 Million
Rs-644.00 Million
≈ $-6.96 Million
-0.110x -182.93%
2018-03-31 Rs5.53 Billion
≈ $59.83 Million
Rs730.90 Million
≈ $7.90 Million
0.132x -26.55%
2017-03-31 Rs5.31 Billion
≈ $57.46 Million
Rs955.66 Million
≈ $10.34 Million
0.180x +17.17%
2016-03-31 Rs5.17 Billion
≈ $55.96 Million
Rs794.30 Million
≈ $8.59 Million
0.154x -7.25%
2015-03-31 Rs5.95 Billion
≈ $64.30 Million
Rs983.98 Million
≈ $10.64 Million
0.166x +83.17%
2014-03-31 Rs7.25 Billion
≈ $78.43 Million
Rs655.29 Million
≈ $7.09 Million
0.090x +265.47%
2013-03-31 Rs8.53 Billion
≈ $92.30 Million
Rs-466.03 Million
≈ $-5.04 Million
-0.055x -161.11%
2012-03-31 Rs8.12 Billion
≈ $87.78 Million
Rs725.24 Million
≈ $7.84 Million
0.089x +193.19%
2011-03-31 Rs5.84 Billion
≈ $63.10 Million
Rs177.83 Million
≈ $1.92 Million
0.030x -69.08%
2010-03-31 Rs4.48 Billion
≈ $48.48 Million
Rs441.84 Million
≈ $4.78 Million
0.099x -64.25%
2009-03-31 Rs3.63 Billion
≈ $39.27 Million
Rs1.00 Billion
≈ $10.83 Million
0.276x +61.91%
2008-03-31 Rs3.33 Billion
≈ $36.06 Million
Rs567.77 Million
≈ $6.14 Million
0.170x +17.18%
2007-03-31 Rs3.11 Billion
≈ $33.68 Million
Rs452.62 Million
≈ $4.89 Million
0.145x +137.58%
2006-03-31 Rs1.92 Billion
≈ $20.80 Million
Rs117.63 Million
≈ $1.27 Million
0.061x --

About Ind-Swift Laboratories Limited

NSE:INDSWFTLAB India Drug Manufacturers - Specialty & Generic
Market Cap
$322.82 Million
Rs29.85 Billion INR
Market Cap Rank
#14153 Global
#702 in India
Share Price
Rs343.75
Change (1 day)
-2.69%
52-Week Range
Rs88.15 - Rs413.10
All Time High
Rs413.10
About

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hy… Read more